Arcturus Therapeutics Holdings Inc
Price
FilingsNewest: Form 13G, stake over 5%, passiveNov 18 →InsidersNo open-market buys or sales.→HoldersFederated Hermes 11.6%ARK 10.2%BlackRock 9.2%→Financing →PeersClosest companies: MRNA, VIR, IBRX→
From the filings
Figures
- Revenue
- $30.5Mlast 12 months
- Net income
- −$87.2Mlast 12 months
- Operating cash flow
- −$72.7Mlast 12 months
- Cash and equivalents
- $184.8Mat the last balance sheet
- Shares outstanding
- 28.5M shareson issue
Filings, newest first
- Nov 1813GStake over 5%, passive
- Nov 168-KMaterial agreement
- Nov 510-QQuarterly report
- Nov 58-KResults of operations
- Sep 238-KRegulation FD disclosure
- Aug 258-KRegulation FD disclosure
- Aug 610-QQuarterly report
- Aug 68-KResults of operations
- Mar 310-KAnnual report
- Aug 19, 20254Insider trade
- Oct 16, 20244Insider trade